Table 4 parameters of metabolism, hemostasis, endogenous fibrinolysis and blood rheology for patients with and without diabetes mellitus
| Â | diabetes mellitus | non-diabetic patients | p-value |
|---|---|---|---|
| Â | n = 44 | n = 194 | Â |
total cholesterol (mg/dl) | 254 ± 69 | 239 ± 43 | n.s. |
hdl - cholesterol(mg/dl) | 42 ± 13 | 45 ± 12 | <0,05 |
ldl - cholesterol(mg/dl) | 188 ± 55 | 173 ± 43 | <0,05 |
triglycerides (mg/dl) | 257 ± 204 | 183 ± 103 | <0,05 |
lipoproteine (a) (mg/dl) | 22 ± 33 | 36 ± 42 | <0,05 |
glucose (mg/dl) | 157 ± 67 | 88 ± 12 | <0,0001 |
tissue -plasminogenactivator (μg/l) | 8,9 ± 3,7 | 8,4 ± 3,0 | n.s. |
plasminogenaktivator-inhibitore (U/ml) | 6,1 ± 5,2 | 4,8 ± 2,7 | <0,05 |
fibrinogen (mg/dl) | 351 ± 76 | 312 ± 64 | <0,01 |
plasma viscosity (mPa × s-1) | 1,38 ± 0,23 | 1,31 ± 0,16 | <0,01 |
red blood cell aggregation M (E) | 8,7 ± 2,1 | 7,3 ± 2,0 | <0,05 |
red blood cell aggregation M1 (E) | 13,2 ± 2,5 | 12,1 ± 3,1 | <0,05 |